⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13979143 | 1.00 | — | — | |
| SCHEMBL3827437 | 1.00 | — | — | |
| SCHEMBL7807707 | 1.00 | — | — | |
| SCHEMBL3827455 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7807610 | 0.99 | — | — | |
| Hydrochloric Acid SCHEMBL7080825 | 0.99 | — | — | |
| Hydrochloric Acid SCHEMBL7080827 | 0.99 | — | — | |
| SCHEMBL4589760 | 0.99 | — | — | |
| SCHEMBL13979122 | 0.88 | — | — | |
| SCHEMBL1267675 | 0.86 | MEN1 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | claimed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | claimed |
| EP-0975595-B9 | ANALOGS OF COCAINE | UNIV GEORGETOWN (US) | 2009-09-16 | — | — | EP | claimed |
| EP-0975595-B1 | ANALOGS OF COCAINE | UNIV GEORGETOWN (US) | 2009-06-17 | — | — | EP | claimed |
| US-6440996-B1 | Monomeric and dimeric heterocycles, and therapeutic uses thereof | GEORGETOWN UNIVERSITY | 2002-08-27 | — | — | US | claimed |
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | disclosed |
| US-10271540-B2 | Medical fluid, a method of treatment and use of the fluid | XVIVO PERFUSION AB (SE) | 2019-04-30 | — | — | US | disclosed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | disclosed |
| US-20160338343-A1 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2016-11-24 | — | — | US | disclosed |
| EP-2568805-A1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | Vivoline Medical AB (SE) | 2013-03-20 | — | — | EP | disclosed |
| US-20130065218-A1 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | VIVOLINE MEDICAL AB (SE) | 2013-03-14 | — | — | US | disclosed |
| WO-2011142705-A1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | VIVOLINE MEDICAL AB (SE) | 2011-11-17 | — | — | WO | disclosed |
| US-20030144322-A1 | Analogs of cocaine | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-31 | — | — | US | disclosed |
| US-6472422-B2 | TREATING DRUG ADDICTION | GEORGETOWN UNIVERSITY | 2002-10-29 | — | — | US | disclosed |
| US-6440996-B1 | Monomeric and dimeric heterocycles, and therapeutic uses thereof | GEORGETOWN UNIVERSITY | 2002-08-27 | — | — | US | disclosed |
| EP-1119553-A1 | MONOMERIC AND DIMERIC HETEROCYCLES, AND THERAPEUTIC USES THEREOF | GEORGETOWN UNIVERSITY (US) | 2001-08-01 | — | — | EP | disclosed |
| US-6180648-B1 | Analogs of cocaine | BIOSTREAM THERAPEUTICS, INC. | 2001-01-30 | — | — | US | disclosed |
| WO-2000020390-A1 | MONOMERIC AND DIMERIC HETEROCYCLES, AND THERAPEUTIC USES THEREOF | GEORGETOWN UNIVERSITY (US) | 2000-04-13 | — | — | WO | disclosed |
| EP-0975595-A1 | ANALOGS OF COCAINE | GEORGETOWN UNIVERSITY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998045263-A1 | ANALOGS OF COCAINE | GEORGETOWN UNIVERSITY (US) | 1998-10-15 | — | — | WO | disclosed |